Develops and markets therapies for disorders of the nervous system.
Acorda is a biotechnology company that develops and markets therapies for multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. Acorda's lead marketed products are Ampyra(dalfampridine) and ZanaflexCapsules (tizanidine hydrochloride) and its pipeline is focused on the treatment, regeneration and repair of the spinal cord and brain.
Sale of listed shares in 2006.
- Industry Biotech
- History IPO